Cyclopharm Limited
CYC
Rank in Stocks
#23694
Cyclopharm Limited is an international enterprise specializing in the... Cyclopharm Limited is an international enterprise specializing in the production and global distribution of medical devices and radiopharmaceuticals, with operations spanning Asia Pacific, Europe, Canada, and other regions. The company's business activities are structured into two principal divisions: Technegas and Molecular Imaging. Through its Technegas segment, Cyclopharm supplies diagnostic apparatus and accompanying consumables critical for clinicians in the identification of pulmonary embolisms, alongside distributing third-party offerings to the broader diagnostic imaging sector. Conversely, the Molecular Imaging division provides advanced radiopharmaceutical agents essential for medical practitioners diagnosing conditions such as cancer, various neurological disorders, and cardiac diseases. Cyclopharm primarily serves nuclear medicine departments. Established in 1986, the company's corporate headquarters are located in Kingsgrove, Australia.
Share Price
$0.31494646
Last synced: 2026-11-09
Market Cap
$39.60M
Change (1 day)
-0.18%
Change (1 year)
-23.39%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cyclopharm Limited (CYC)
Category
Healthcare
Operating Margin for Cyclopharm Limited (CYC)
Operating Margin as of November 2026 TTM: -51.62%
According to Cyclopharm Limited's latest financial reports, its current operating margin (TTM) is -51.62%. At the end of 2025 the company had an operating margin of -56.25%.
Operating Margin history for Cyclopharm Limited from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -51.62% | -8.23% |
| 2025 | -56.25% | 8.11% |
| 2024 | -52.03% | 160.41% |
| 2023 | -19.98% | -36.27% |
| 2022 | -31.35% | -13.73% |
| 2021 | -36.34% | 27.96% |
| 2020 | -28.40% | -32.12% |
| 2019 | -41.84% | 120.79% |
| 2018 | -18.95% | 85.24% |
| 2017 | -10.23% | -172.76% |
| 2016 | 14.06% | -31.35% |
| 2015 | 20.48% | -31.04% |
| 2014 | 29.70% | -638.04% |
| 2013 | -5.52% | -5.48% |
| 2012 | -5.84% | -27.99% |
| 2011 | -8.11% | -176.22% |
| 2010 | 10.64% | -58.92% |
| 2009 | 25.90% | 31.14% |
| 2008 | 19.75% | 36.21% |
| 2007 | 14.50% | -42.71% |
| 2006 | 25.31% | 0.00% |
| 2005 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.30% |
US
|
|
| 18.08% | -100.35% |
IE
|
|
| 21.25% | -100.41% |
US
|
|
| 21.05% | -100.41% |
US
|
|
| 28.09% | -100.54% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Cyclopharm Limited's operating margin
What is Cyclopharm Limited's operating margin?
Cyclopharm Limited's operating margin is -51.62%, as of Nov 2026.
What was Cyclopharm Limited's operating margin in 2025?
In 2025, Cyclopharm Limited's operating margin was -56.25%, compared with -52.03% in 2024.
How has Cyclopharm Limited's operating margin changed since 2020?
From 2020 to 2025, Cyclopharm Limited's operating margin was highest in 2023 (-19.98%) and lowest in 2025 (-56.25%).
How does Cyclopharm Limited's operating margin compare with similar companies?
Cyclopharm Limited's operating margin (-51.62%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.